- Home
- YTRA vs IFRX Comparison
YTRA vs IFRX Comparison
Compare YTRA & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YTRA | IFRX |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | India | Germany |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.4M | 66.0M |
| IPO Year | 2011 | 2017 |
Fundamental Metrics
Financial Performance| Metric | YTRA | IFRX |
|---|---|---|
| Price | $1.15 | $1.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.00 | ★ $7.00 |
| AVG Volume (30 Days) | 47.5K | ★ 468.2K |
| Earning Date | 05-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3,018.21 |
| Revenue Next Year | $5.59 | $91.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $0.71 |
| 52 Week High | $2.00 | $1.94 |
Technical Indicators
Market Signals| Indicator | YTRA | IFRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.17 | 82.82 |
| Support Level | $0.98 | $1.12 |
| Resistance Level | $1.25 | $1.77 |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 69.33 | 86.20 |
Price Performance
Historical ComparisonAbout YTRA Yatra Online Inc.
Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.
About IFRX InflaRx N.V.
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.